Moffitt researchers compare chemotherapy regimens for best outcomes in invasive bladder cancer

(H. Lee Moffitt Cancer Center& Research Institute) Patients with muscle-invasive bladder cancer have been shown to benefit from chemotherapy prior to surgical removal of the bladder. But which type of chemotherapy leads to the best outcomes in terms of complete response rates or cancer control? Moffitt Cancer Center researchers examined data from more than 800 surgical patients with advanced bladder cancer. The results, published online by JAMA Oncology, show higher likelihoods of complete response or down-staging associated with a chemotherapeutic combination called ddMVAC.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news